Product NDC: | 63323-162 |
Proprietary Name: | Ketorolac Tromethamine |
Non Proprietary Name: | KETOROLAC TROMETHAMINE |
Active Ingredient(s): | 30 mg/mL & nbsp; KETOROLAC TROMETHAMINE |
Administration Route(s): | INTRAMUSCULAR |
Dosage Form(s): | INJECTION, SOLUTION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 63323-162 |
Labeler Name: | Fresenius Kabi USA, LLC |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA075784 |
Marketing Category: | ANDA |
Start Marketing Date: | 20001018 |
Package NDC: | 63323-162-01 |
Package Description: | 25 VIAL, SINGLE-DOSE in 1 TRAY (63323-162-01) > 2 mL in 1 VIAL, SINGLE-DOSE |
NDC Code | 63323-162-01 |
Proprietary Name | Ketorolac Tromethamine |
Package Description | 25 VIAL, SINGLE-DOSE in 1 TRAY (63323-162-01) > 2 mL in 1 VIAL, SINGLE-DOSE |
Product NDC | 63323-162 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | KETOROLAC TROMETHAMINE |
Dosage Form Name | INJECTION, SOLUTION |
Route Name | INTRAMUSCULAR |
Start Marketing Date | 20001018 |
Marketing Category Name | ANDA |
Labeler Name | Fresenius Kabi USA, LLC |
Substance Name | KETOROLAC TROMETHAMINE |
Strength Number | 30 |
Strength Unit | mg/mL |
Pharmaceutical Classes | Cyclooxygenase Inhibitors [MoA],Nonsteroidal Anti-inflammatory Compounds [Chemical/Ingredient],Nonsteroidal Anti-inflammatory Drug [EPC] |